Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug - In a surprising turnabout, drugmaker Gilead Sciences asked the Food & Drug admin to rescind orphan status for remdesivir, the company's experimental coronavirus treatment.

Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug - In a surprising turnabout, drugmaker Gilead Sciences asked the Food & Drug admin to rescind orphan status for remdesivir, the company's experimental coronavirus treatment.: https://ift.tt/2UySq1L Read more... https://ift.tt/2QUqi87